Costimulatory signaling from CD28 is associated with improved CAR T-cell expansion and persistence after their infusion into the patient’s blood stream, with excellent results in indolent B-cell malignancies, as well in ALL. The gene discussed is CD28; the disease is acute lymphoblastic leukemia.